These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31659220)

  • 1. Broad and Efficient Control of Klebsiella Pathogens by Peptidoglycan-Degrading and Pore-Forming Bacteriocins Klebicins.
    Denkovskienė E; Paškevičius Š; Misiūnas A; Stočkūnaitė B; Starkevič U; Vitkauskienė A; Hahn-Löbmann S; Schulz S; Giritch A; Gleba Y; Ražanskienė A
    Sci Rep; 2019 Oct; 9(1):15422. PubMed ID: 31659220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stenocins: Novel modular bacteriocins from opportunistic pathogen Stenotrophomonas maltophilia.
    Paškevičius Š; Gleba Y; Ražanskienė A
    J Biotechnol; 2022 Jun; 351():9-12. PubMed ID: 35436577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections.
    Ghodhbane H; Elaidi S; Sabatier JM; Achour S; Benhmida J; Regaya I
    Infect Disord Drug Targets; 2015; 15(1):2-12. PubMed ID: 24853876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant symbiotic bacteria associated with wild medfly populations reveal a bacteriocin-like killing phenotype: a 'cold-case' study.
    Ciolfi S; Marri L
    Bull Entomol Res; 2020 Aug; 110(4):457-462. PubMed ID: 31813393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antimicrobial spectrum of the action of bacteriocins and bacteriophages from Klebsiella strains].
    Sharga BM; Turianitsa AI
    Mikrobiol Z; 1993; 55(5):59-68. PubMed ID: 8162198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Natural Chimeric
    Ghequire MG; Kemland L; Anoz-Carbonell E; Buchanan SK; De Mot R
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts.
    Elisha IL; Botha FS; McGaw LJ; Eloff JN
    BMC Complement Altern Med; 2017 Feb; 17(1):133. PubMed ID: 28241818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispecies activity screening of microcin J25 mutants yields antimicrobials with increased specificity toward pathogenic Salmonella species relative to human commensal Escherichia coli.
    Ritter SC; Yang ML; Kaznessis YN; Hackel BJ
    Biotechnol Bioeng; 2018 Oct; 115(10):2394-2404. PubMed ID: 29940080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and uptake mechanism of bacteriocins targeting peptidoglycan renewal.
    Zeth K
    Biochem Soc Trans; 2012 Dec; 40(6):1560-5. PubMed ID: 23176517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial substances produced by coliform strains active against foodborne pathogens.
    Fleming LR; Bolzan DN; Nascimento Jdos S
    Foodborne Pathog Dis; 2010 Mar; 7(3):243-7. PubMed ID: 19895262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriocins as tools in analysis of nosocomial Klebsiella pneumoniae infections.
    Bauernfeind A; Petermüller C; Schneider R
    J Clin Microbiol; 1981 Jul; 14(1):15-9. PubMed ID: 6790566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lectin-like bacteriocins of biocontrol strain Pseudomonas fluorescens Pf-5.
    Parret AH; Temmerman K; De Mot R
    Appl Environ Microbiol; 2005 Sep; 71(9):5197-207. PubMed ID: 16151105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three immunity types of klebicins which use the cloacin DF13 receptor of Klebsiella pneumoniae.
    Cooper PC; James R
    J Gen Microbiol; 1985 Sep; 131(9):2313-8. PubMed ID: 3906039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens.
    Bendjeddou K; Fons M; Strocker P; Sadoun D
    World J Microbiol Biotechnol; 2012 Apr; 28(4):1543-52. PubMed ID: 22805936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against gram-negative bacteria in combination with EDTA treatment.
    Martin-Visscher LA; Yoganathan S; Sit CS; Lohans CT; Vederas JC
    FEMS Microbiol Lett; 2011 Apr; 317(2):152-9. PubMed ID: 21255070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Bacteriocins from
    Belguesmia Y; Hazime N; Kempf I; Boukherroub R; Drider D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212803
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for Widespread Class II Microcins in
    Cole TJ; Parker JK; Feller AL; Wilke CO; Davies BW
    Appl Environ Microbiol; 2022 Dec; 88(23):e0148622. PubMed ID: 36394322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance in Salmonella enterica serovar Typhimurium exposed to microcin-producing Escherichia coli.
    Carlson SA; Frana TS; Griffith RW
    Appl Environ Microbiol; 2001 Aug; 67(8):3763-6. PubMed ID: 11472964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colicin M, a peptidoglycan lipid-II-degrading enzyme: potential use for antibacterial means?
    Touzé T; Barreteau H; El Ghachi M; Bouhss A; Barnéoud-Arnoulet A; Patin D; Sacco E; Blanot D; Arthur M; Duché D; Lloubès R; Mengin-Lecreulx D
    Biochem Soc Trans; 2012 Dec; 40(6):1522-7. PubMed ID: 23176510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.